1-5 of 5
Ethan Troy-Barnes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Physician Knowledge Regarding Voxelotor for the Treatment of Sickle Cell Disease in England and Wales - a National Survey

Ethan Troy-Barnes, Chloe Merrion, Lorna Cain, Richard John Buka, Ana Ortuno Cabrero, Ryan Mullally, Emma Drasar
Journal: Blood
Blood (2024) 144 (Supplement 1): 5344.
https://doi.org/10.1182/blood-2024-205550
Published: 2024
Journal Articles

Immunoglobulin Replacement Therapy (IgRT) for the Treatment of Haematological Malignancy Associated Secondary Immunodeficiency (HM-SID) - a Large UK Tertiary Centre Experience

Zin Aung J Soe, Ahmed Eldarwi, Ethan Troy-Barnes, Rahi Patel, Dario Melotti, Anish Tailor, Samah Alimam
Journal: Blood
Blood (2024) 144 (Supplement 1): 2537.
https://doi.org/10.1182/blood-2024-198935
Published: 2024
Journal Articles

Observational Data on Parvovirus B19 Cases in Patients with Red Cell Disorders in the United Kingdom from 2023-2024

Chloe Merrion, Ethan Troy-Barnes, Ryan Mullally, Ana Ortuno Cabrero, John B. Porter, Emma Drasar
Journal: Blood
Blood (2024) 144 (Supplement 1): 3895.
https://doi.org/10.1182/blood-2024-208518
Published: 2024
Journal Articles

Glofitamab (Glofit) Plus R-CHOP Has a Favorable Safety Profile and Induces High Response Rates in Patients with Previously Untreated (1L) Large B-Cell Lymphoma (LBCL) Defined As High Risk By Circulating Tumor DNA (ctDNA) Dynamics: Preliminary Safety and Efficacy Results

Lorenzo Falchi, Fabrice Jardin, Corinne Haioun, Tomasz Wrobel, Judit Mészáros Joergensen, Mariana Bastos-Oreiro, Eric Mou, Joaquin Martinez-Lopez, L. Elizabeth Budde, Nancy L. Bartlett, Jan M. Zaucha, Alejandro Martin Garcia-Sancho, Rutanshu Shah, Nathan Rees, Ron McCord, Alexandra Bazeos, Maneesh Tandon, Michelle Doral, Ethan Troy-Barnes, Marcel Nijland
Journal: Blood
Blood (2023) 142 (Supplement 1): 858.
https://doi.org/10.1182/blood-2023-173953
Published: 2023
Journal Articles

Early Results Indicate Acceptable Safety and Promising Efficacy of Venetoclax in Combination with Pola-R-CHP for Untreated High-Risk BCL-2-Positive B-Cell Lymphoma Including Double/Triple Hit Lymphoma

Andrew D. Zelenetz, Catherine S. Diefenbach, Charles Herbaux, Monica Tani, Roch Houot, Mariana Bastos-Oreiro, Herve Tilly, Thomas Gastinne, Catherine Thieblemont, Ethan Troy-Barnes, Stefano Olivieri, Murali Kesavan, Manisha Kanwar, Simona Barlera, Katerina Hatzi, Yanwen Jiang, Michelle Boyer, Franck Morschhauser
Journal: Blood
Blood (2023) 142 (Supplement 1): 439.
https://doi.org/10.1182/blood-2023-174855
Published: 2023